S&P ASX All Technology

3,635.00

0.14%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
Mallinckrodt Plc (MNK)
Mallinckrodt Plc (MNK) News

MNK

Mallinckrodt (MNK)

Mallinckrodt Plc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:MNK

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
28/02/2025	05:00	PR Newswire (US)	Mallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results	NYSE:MNK	Mallinckrodt Plc
02/12/2024	22:45	PR Newswire (US)	Mallinckrodt Completes Divestiture of Therakos® Business	NYSE:MNK	Mallinckrodt Plc
19/11/2024	03:00	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
15/11/2024	01:05	PR Newswire (US)	Mallinckrodt to Present at Jefferies London Healthcare Conference	NYSE:MNK	Mallinckrodt Plc
05/11/2024	22:45	PR Newswire (US)	Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
30/10/2024	21:50	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
29/10/2024	23:30	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting	NYSE:MNK	Mallinckrodt Plc
27/10/2024	04:00	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024	NYSE:MNK	Mallinckrodt Plc
24/10/2024	21:45	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Third Quarter 2024	NYSE:MNK	Mallinckrodt Plc
10/10/2024	21:52	PR Newswire (US)	Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals	NYSE:MNK	Mallinckrodt Plc
17/09/2024	20:50	PR Newswire (US)	Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector	NYSE:MNK	Mallinckrodt Plc
03/09/2024	17:45	PR Newswire (US)	THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)	NYSE:MNK	Mallinckrodt Plc
06/08/2024	20:45	PR Newswire (US)	Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
06/08/2024	20:35	PR Newswire (US)	Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.	NYSE:MNK	Mallinckrodt Plc
05/08/2024	21:00	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	NYSE:MNK	Mallinckrodt Plc
05/08/2024	21:00	PR Newswire (US)	Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million	NYSE:MNK	Mallinckrodt Plc
01/08/2024	22:59	PR Newswire (US)	Mallinckrodt to Report Earnings Results for Second Quarter 2024	NYSE:MNK	Mallinckrodt Plc
05/06/2024	20:45	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 European Association for the Study of the Liver (EASL) Congress	NYSE:MNK	Mallinckrodt Plc
18/05/2024	21:00	PR Newswire (US)	Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)	NYSE:MNK	Mallinckrodt Plc
09/05/2024	20:45	PR Newswire (US)	Mallinckrodt plc Reports First Quarter 2024 Financial Results and Reaffirms Full Year Guidance	NYSE:MNK	Mallinckrodt Plc
27/03/2024	07:01	PR Newswire (US)	Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance	NYSE:MNK	Mallinckrodt Plc
11/03/2024	21:52	PR Newswire (US)	Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients	NYSE:MNK	Mallinckrodt Plc
04/03/2024	22:45	PR Newswire (US)	Mallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands	NYSE:MNK	Mallinckrodt Plc
02/03/2024	00:50	PR Newswire (US)	Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector	NYSE:MNK	Mallinckrodt Plc
03/02/2024	00:45	PR Newswire (US)	Mallinckrodt Announces Board of Directors and Leadership Updates	NYSE:MNK	Mallinckrodt Plc
22/01/2024	22:52	PR Newswire (US)	Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress	NYSE:MNK	Mallinckrodt Plc
01/11/2023	21:45	PR Newswire (US)	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting	NYSE:MNK	Mallinckrodt Plc
26/10/2023	21:53	PR Newswire (US)	Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023	NYSE:MNK	Mallinckrodt Plc
31/08/2023	01:54	PR Newswire (US)	Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations	NYSE:MNK	Mallinckrodt Plc
30/06/2023	08:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:MNK	Mallinckrodt Plc